1: Yu R, Hou C, Peng Y, Zhu X, Shi C, Huang D, Miao Y, Li Q. The mechanism underlying ICAM-1 and E-selectin-mediated hypertriglyceridemic pancreatitis- associated lung injury. Mol Immunol. 2022 Dec;152:55-66. doi: 10.1016/j.molimm.2022.10.001. Epub 2022 Oct 21. PMID: 36279659.
2: Oh KK, Adnan M, Cho DH. New Insight into Drugs to Alleviate Atopic March via Network Pharmacology-Based Analysis. Curr Issues Mol Biol. 2022 May 18;44(5):2257-2274. doi: 10.3390/cimb44050153. PMID: 35678682; PMCID: PMC9164039.
3: Stewart AO, Bhatia PA, McCarty CM, Patel MV, Staeger MA, Arendsen DL, Gunawardana IW, Melcher LM, Zhu GD, Boyd SA, Fry DG, Cool BL, Kifle L, Lartey K, Marsh KC, Kempf-Grote AJ, Kilgannon P, Wisdom W, Meyer J, Gallatin WM, Okasinski GF. Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expression. J Med Chem. 2001 Mar 15;44(6):988-1002. doi: 10.1021/jm000452m. PMID: 11300880.
4: Zhu GD, Arendsen DL, Gunawardana IW, Boyd SA, Stewart AO, Fry DG, Cool BL, Kifle L, Schaefer V, Meuth J, Marsh KC, Kempf-Grote AJ, Kilgannon P, Gallatin WM, Okasinski GF. Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem. 2001 Oct 11;44(21):3469-87. doi: 10.1021/jm0101702. PMID: 11585452.
5: Zhu GD, Schaefer V, Boyd SA, Okasinski GF. Synthesis and mode of action of (125)I- and (3)H-labeled thieno[2,3-c]pyridine antagonists of cell adhesion molecule expression. J Org Chem. 2002 Feb 8;67(3):943-8. doi: 10.1021/jo016171j. PMID: 11856042.